Targeted metabolomics reveals reduced levels of polyunsaturated choline plasmalogens and a smaller dimethylarginine/arginine ratio in the follicular fluid of patients with a diminished ovarian reserve SUMMARY ANSWER: The metabolomic signature of the FF reveals a significant decrease in polyunsaturated choline plasmalogens and methyl arginine transferase activity in DOR patients compared to NOR patients.
Introduction
Ovarian ageing is one of the common causes of infertility (http:// presse.inserm.fr/les-troubles-de-la-fertilite-etat-des-connaissances-etpistes-pour-la-recherche-2/6060/) with almost 20% of patients consulting for infertility showing signs of premature ovarian ageing (Devine et al., 2015) . However, assisted reproductive technology is frequently inefficacious in these cases. It is therefore essential to understand the pathophysiological mechanisms of ovarian ageing so as to provide adequate counseling to affected women desiring pregnancy.
Ovarian ageing results in both the quantitative and qualitative decline of the ovarian oocyte reserve (te Velde and Pearson, 2002) . Clinically, ovarian ageing is characterized by a diminished ovarian reserve (DOR) objectified by markers such as the decrease in the anti-Müllerian hormone (AMH), the increase in the FSH, and the decrease in the antral follicle count (AFC). Women with DOR also present impaired oocyte competence, resulting in an increase of embryonic aneuploidies (Haadsma et al., 2010; van der Stroom et al., 2011; Katz-Jaffe et al., 2013) , fertilization failure (Lekamge et al., 2007) , high rates of pregnancy loss (Levi et al., 2001; Lekamge et al., 2007) , as well as poor response to ovarian stimulation, and reduced chances of pregnancy with IVF (Bancsi et al., 2002; Nikolaou and Templeton, 2003) .
Oocyte competence to support embryonic development is acquired within the ovarian follicle. The structure of the ovarian follicle evolves during folliculogenesis and, from the tertiary stage, the follicle comprises an antrum filled with follicular fluid (FF). The FF is produced both by the transfer of blood plasma components across the blood follicular barrier, by secretions of the theca and the granulosa cells, and by molecules excreted by the oocyte (Fortune, 1994) . The composition of the FF, reflects the exchanges contributing to the acquisition of oocyte competence and has been associated with oocyte quality, embryonic development and the fertility of women (Revelli et al., 2009) . In this context, it has been suggested that the FF should be searched for biomarkers of oocyte maturity, fecundity, and embryonic viability (Basuino and Silveira, 2016) . Omics technologies, i.e. genomics, transcriptomics, proteomics, metabolomics and fluxomics, which allow the detection of large sets of molecules in a single experiment, have been used to identify potential biomarkers in the FF (McRae et al., 2012) . The integrated analysis of 'omics' data, obtained from several FF studies, has also enabled the identification of specific markers or pathways underlying certain pathologies, such as endometriosis (Cordeiro et al., 2015a) or polycystic ovary syndrome (Atiomo and Daykin, 2012; Sun et al., 2012; Cordeiro et al., 2015b) .
Previous targeted studies have reported variations of some specific metabolites in the FF from older women or patients with reduced ovarian reserve, including an increase of the advanced glycation endproduct (AGE) (Fujii and Nakayama, 2010; Tatone et al., 2011; Stensen et al., 2014) and the modification of key metabolites implied in the energetic metabolism of the oocyte (Pacella et al., 2012) . Differences in the proteomics profile (Hashemitabar et al., 2014) and the lipidomics profile (Von Wald et al., 2010; Cataldi et al., 2013) have also been evidenced. Here, we hypothesized a possible global impact of ageing and DOR on the metabolome of the FF. To address this question, we conducted a targeted metabolomics study, measuring 188 metabolites using mass spectrometry on the FF from 28 women with ovarian ageing characterized by DOR and 29 women with a normal ovarian profile (NOR) serving as controls.
Materials and Methods
Characteristics of the patients FF was obtained from 57 patients, 28 with a DOR and 29 with a normal ovarian reserve (NOR), all undergoing IVF with or without ICSI at the ART centre of the University Hospital of Angers, France, between November 2015 and September 2016. The criteria used for classifying the patients into the DOR or NOR groups included the levels of AMH, FSH and estradiol, as well as the results of ovarian ultrasonography and the antral follicle count (AFC) (de Carvalho et al., 2008) . Except for the AMH assays, all of the other dosages and ultrasonography examinations were performed on Day 3 of a spontaneous ovarian cycle. Patients were considered to belong to the NOR group if they had AMH levels above two ng/ml, FSH levels below eight IU/l, estradiol levels below 60 pg/ml, and an AFC above four per ovary. Patients were considered to belong to the DOR group if they had AMH levels below two ng/ml or an AFC below five per ovary. Since there is no consensus concerning the definition of DOR, the classification used here was based on our centre specific data, as advocated by the Practice Committee of the American Society for Reproductive 2015 (Practice Committee of the American Society for Reproductive Medicine, 2015) .
All of the women included in the study had two ovaries, with no history of ovarian surgery, or any autoimmune disease or gonadotoxic treatment that might have contributed to a DOR. Patients with polycystic ovary syndrome or endometriosis were excluded. 
Metabolomics analyses
Targeted quantitative metabolomics analyses were carried out using the Biocrates ® Absolute IDQ p180 kit (Biocrates Life sciences AG, Innsbruck, Austria). This kit, combined with a QTRAP 5500 mass spectrometer (SCIEX, Villebon-sur-Yvette, France), enabled quantification of up to 188 different endogenous molecules: free carnitine and 39 acylcarnitines; 21 amino acids; 21 biogenic amines; the sum of hexose and 90 lipids, comprising 14 lysophosphatidylcholines, 38 diacyl-phosphatidylcholines (referred to as PC aa), and 38 choline plasmalogens (ChoPls) (referred to as PC ae); and 15 sphingomyelins (referred to as SM). The full list of individual metabolites is available at http://www.biocrates.com/products/researchproducts/absoluteidq-p180-kit. Flow injection analysis coupled with tandem mass spectrometry (FIA-MS/MS) was used for the analysis of carnitines, acylcarnitines, lipids and sugar, whereas liquid chromatography (LC) was used for separating amino acids and biogenic amines before quantitation with MS. All reagents used in this analysis were of LC-MS grade and purchased from VWR (Fontenay-sous-Bois, France) and Merck (Molsheim, France). Sample preparation was performed following the Kit User Manual. Briefly, each FF was thoroughly vortexed after thawing and centrifuged at 4°C for 5 min at 5000 g. For each sample, 10 μl was then added to the centre of the filters placed on the upper wells of the 96-well plate. Metabolites were extracted in a methanol solution using ammonium acetate after drying the filter spot under nitrogen flow and derivatizing with phenylisothiocyanate for the quantitation of amino acids and biogenic amines. The extracts were finally diluted with MS running solvent before FIA and LC-MS-MS analysis. One blank sample (with no internal standard or sample added), three water-based zero samples (internal standards added and phosphate buffered saline as a 'zero' sample), and three quality control (QC) samples were also added to the plate of the kit. Three QCs composed of human plasma samples at three concentration levels: low (QC1), medium (QC2) and high (QC3), were used to evaluate the performance of the analytical assay. A seven-point serial dilution of calibrators was added to the plate of the kit to generate calibration curves for the quantification of amino acids and biogenic amines.
In addition to the information gathered from individual metabolites, several sums and ratios, with metabolic significance in a wide range of disorders belonging to the metabolic disease spectrum, were calculated using the RatioExplorer module provided by Biocrates ® (Table II) .
Statistical analyses
The univariate statistical analysis of the data of the patients was done using the non-parametric Mann-Whitney test for quantitative variables and the chi-squared test (χ 2 ) for quantitative variables. No corrections for Type I error inflation were used. All the calculations were done with Systat software, version 15.0 (SPSS Inc., Chicago, IL, USA). Differences were considered significant at P < 0.05.
Raw data were first examined in order to eliminate metabolites not accurately measured, i.e. when >20% of metabolite concentration values were out of the dynamic range. The univariate analysis of metabolomic data was done using the non-parametric Mann-Whitney test for comparisons involving two independent samples. Fisher's exact test was used for testing the null hypothesis of independence of the rows and columns in the confusion matrices. Differences were considered significant at P < 0.05. All univariate analyses involving metabolomics data were done with R software, version 3.2.1 (http://www.Rproject.org).
Multivariate analysis
In order to evaluate the generalizability of model predictions, the data were randomly split in a training set containing about two-thirds of all the data (e.g. 20 NOR and 20 DOR patients) and a test set containing about one-third of the data (e.g. nine NOR and eight DOR patients). Multivariate analyses were performed on the training set and the prediction capabilities of this model were evaluated on the independent test set. First, principal components analysis (PCA) was used on the training set to detect sample groups and outliers. Then, OPLS-DA, which is a supervised pattern recognition method, was performed to maximize the variation between groups and to determine the variables contributing to this variation. Multivariate analyses for the PCA and OPLS-DA models were performed using meancentered and unit variance-scaled (MC-UV) data. The quality of the models was validated using two parameters: R 2 (goodness of fit) and cumulated
cum, goodness of prediction). A threshold of 0.5 was used to identify good (Q 2 cum ≥ 0.5) or poor (Q 2 cum < 0.5) predictive capabilities in the models created with the training set using cross-validation (Eriksson et al., 2006) . In order to avoid over-fitting, superfluous variables based on VIP (Variable Importance for the projection) and loading values (see below) were eliminated from the initial model using a backward procedure. The risk of over-fitting and robustness for the final model constructed in the training set was assessed by the intercept of the permutation plot and the cross-validated ANOVA (CV-ANOVA), respectively. This intercept reflects the predictive capabilities (permQ 2 ) of a model having the same number of components (or latent variables) and the same X training matrix (metabolites) but a randomly permuted Y training vector (scrambled Y training ) of response variables, i.e. there is no correlation at the intercept between the original Y training vector and the permuted Y training vector. Nonover-fitted models have negative permQ 2 value (MKS Umetrics, 2013). In the CV-ANOVA test, the CV-predicted residuals using the OPLS model are compared, using an ANOVA test, to the residuals obtained as a variation around the Y training -average. When the null hypothesis of equality of the two residuals (F-test) cannot be rejected (P-value > 0.05 here), the equality of the OPLS and a random model cannot be rejected (Eriksson et al., 2008) . In the model with the best predictive capabilities, key variables were highlighted on the basis of the variable importance for the projection (VIP), and loading values scaled as correlation coefficients (p corr ). VIP values summarize the importance of each variable for the OPLS-DA model, while loadings are indicators of the relationship between Y training vector (NOR or DOR class) and X training variables (matrix of measured metabolites in the training set). Variables having a VIP value greater than one are considered to be important for group discrimination in predictive models (Eriksson et al., 2006) . Plotting VIP versus p corr values ('volcano' plot) enabled highlighting important variables in PLS models. Multivariate data analysis was conducted using SIMCA-P v.14.0 (Umetrics, Umeå, Sweden). To evaluate the generalizability of the predictions made by the model created with the training set, this model was applied to the test set (X test ,) and the predicted responses (NOR or DOR) obtained (Y pred,test ) were compared to the actual responses (Y test ) using Fisher's exact test. We performed a LASSO (Least Absolute Shrinkage and Selection Operator) logistic regression (LASSO-LR) on the MC-UV scaled ratios or sum of metabolites for the training set. With this method, a constraint or penalty is imposed to the coefficients of the 'classic' logistic regression in order to render the variance-covariance matrix invertible thus enabling the computation of variance estimate for the regression coefficients (Tibshirani, 1996) . This method is considered as a variable selection method since some coefficients are shrunk toward exactly zero under the constraint. We then applied a logistic regression model with a backward selection procedure and minimization of the Akaike information criterion to the variables having no null coefficient after the LASSO-LR. Indeed, the coefficients estimated in LASSO-LR are biased because of the penalty whereas the coefficients estimated after LR are not biased, enabling the calculation of risk measurements from coefficients such as odds ratios (OR). Finally, the model obtained by LR was applied to the MC-UV scaled ratios or sum of metabolites in the test set to measure its capacity to predict the outcome (NOR or DOR) in a new data set. Fisher's exact test was used to test the independence between the predicted and actual outcomes under the null hypothesis. LASSO-LR and LR were performed using the R packages glmnet and glm, respectively (http://www.Rproject.org).
Ethical approval
All participants gave their written informed consent and the collection of samples was approved by the Ethical Committee of the University Hospital of Angers, France (Number DC-2014-2224).
Results

Characteristics of patients
As expected, since plasma AMH, AFC and FSH levels were the criteria initially used for classifying the patients into the DOR and NOR groups, the values of the AMH and the AFC were significantly lower whereas that of the FSH was significantly higher in the DOR group compared to the NOR group of patients. In addition, the mean number of OCCs retrieved was lower in the DOR group than in the NOR group of patients (Table I) . Not surprisingly, the doses of FSH required for the stimulation phase were significantly higher in the DOR group than in the NOR group of patients. However, there was no significant difference between the two groups of patients with respect to the drugs used for LH suppression and ovarian stimulation ( Table I) .
The mean age was significantly lower in the NOR group than in the DOR group of patients. However, there were no significant differences between the two groups in terms of the BMI or addiction to tobacco smoking, which are factors known to affect the ovarian reserve (Table I) .
Metabolomics analyses
After validation of the plate based on QC samples (data not shown), 136 (72.3%) metabolites were retained for statistical analyses. From the 27 ratios or sums of metabolites (see Table II ), 23 were finally calculated since the metabolites used for the computation of the remaining four ratios, i.e. the ratios of symmetric dimethylarginine (SDMA), sulfoxidized methionine (Met-SO), hexadecanoylcarnitine (C16) and octadecanoylcarnitine (C18), and serotonin, were not accurately measured. Raw data with the full list of metabolites, as well as their ratios and sums, are shown in Supplementary Tables SI and SII, respectively.
The PCA scatter plot of metabolomics data from the FF in the training set showed no grouping according to the NOR or DOR groups nor any strong outliers in the first principal plan (PC1 vs. PC2) (Fig. 1A) . The OPLS-DA model provided a good fit for the data (R 2 X = 0.62, R 2 Y = 0.92) and showed good predictive capability (Q 2 cum = 0.76), with a low risk of over-fitting (permQ 2 = −0.97, CV-ANOVA < 0.0001). A clear discrimination between the DOR and NOR groups along the predictive component (LV1) was apparent in the scatter plot of the OPLS-DA model (Fig. 1B) . The best discriminant metabolites (VIP≥1 and high absolute p corr values) included those related to lipid metabolism, mainly polyunsaturated ChoPls (PUFA ae), with lower concentrations in the FF of DOR patients (Fig. 2) with VIP ≥ 1 were ChoPls, and 19 of the 25 (76%) PUFA ChoPls measured were considered to be important in discriminating between the FF from NOR and DOR patients. Interestingly, the signature encompasses neither any amino acids, nor lysophosphatidylcholine or hexose, and only one acyl-carnitine (propionyl-carnitine or C3, VIP = 1.01).
When applied to the test set, the OPLS-DA model correctly predicted five of the eight DOR cases (62.5%), and 8 of the nine NOR cases (88.9%), P-value = 0.043.
After LASSO, only three variables without null coefficients, i.e. Total DMA/Arg, UFA/SFA ae and PUFA ae, were included in the full logistic values, were seven diacyl PCs (PC aa, light orange bubbles), two sphingomyelins (SM, yellow bubbles), propionyl-carnitine (C3, brown bubble), and total dimethylarginine (total DMA, green bubble). For phosphatidylcholines (PC), the sum of the length of the two acyl groups is noted after the C and is followed by the number of double bonds, e.g. PC ae C42:4 represents a choline plasmalogen where the length of the two acyl chains and the number of double bonds correspond to 42 and 4, respectively. The same notation is used for representing the length and the number of double bonds in the acyl chain of sphingomyelins (SM). regression model. We have added the age of the patient as a variable in the model since the DOR patients were significantly older than the NOR patients. A logistic regression model containing these variables and their first-order interaction was then submitted to a backward elimination procedure. The final LR model after the logit transformation was given by: Here, the negative coefficients indicate that the probability of the patient having a DOR decreases with the increase in these ratios or sums. Although ORs can be directly calculated from this model, the mean centering of the data and UV scaling complicate this task. When this model was applied to the test set, 7 of the 8 (87.5%) DOR cases and all 9 (100%) NOR cases were correctly predicted (P-value < 0.001). Thus, according to the results for the OPLS-DA and LR models on the test set, the latter appears to offer greater specificity and sensitivity.
Box plots for the two ratios and the sums of polyunsaturated choline plasmalogens (PUFA ae) calculated for the 29 NOR and 28 DOR patients are represented in Figure 3 .
The direct correlations between the three variables retained and the markers of ovarian ageing are shown in Supplementary Table SIII. We found significant positive correlations between the three variables retained and two of the markers conventionally used for the evaluation of the ovarian reserve of the patients, i.e. AMH and AFC. In addition, positive correlations were also found between these three variables and the number of OCCs retrieved, which, by definition, is lower in DOR patients.
Discussion
The metabolic signature, based on the OPLS-DA method, was mainly characterized by decreased polyunsaturated ChoPls or PUFA ae in the FF of the DOR patients compared to that of the NOR patients. The other multivariate approach using LASSO yielded a sparse model with only three non-zero coefficients, i.e. the sum of PUFA ae and the ratios of Total DMA to Arginine, and UFA to SFA ae. In order to calculate nonbiased coefficients and to study first-order interactions, we used these variables in a logistic regression model including the patient's age as a confounding factor in the relationship between the variables retained and the NOR or DOR classes of patients. The final LR model contained three variables with no interactions, i.e. PUFA ae, the total DMA/Arginine ratio and the patient's age. This emphasizes the importance of the metabolic signature in distinguishing between DOR and NOR patients, independently of the patients' age. Both the OPLS-DA and the LASSO-LR models highlighted the role played by the polyunsaturated ChoPls, in distinguishing between NOR and DOR patients. However, the LASSO-LR model outperformed the OPLS-DA model certainly in relation to the inclusion of the patient's age in this model and the greater complexity of the OPLS-DA model (with more variables than the LASSO model, leading to some over-fitting and thus to a poorer performance in the test set) and because the LASSO-LR model was more parsimonious since each sum or ratio captured information from several metabolites. Interestingly, AMH and AFC, as well as the number of oocytes retrieved, were positively correlated with the three variables retained by our analysis (Supplementary Table SIII) .
ChoPls along with plasmanylcholines belong to the chemical family of ether-linked glycerophospholipids, a family that is completed mainly by their 'ethanolamine counterparts', i.e. ethanolamine plasmalogens (EtPls) and plasmanylethanolamines (Snyder et al., 2002) . Human plasma Pls, which are synthesized in the peroxisomes of the liver, intestine and kidney, are secreted into the blood as lipoprotein components (Braverman and Moser, 2012) . In spite of numerous studies on the biochemical composition of FF, including some metabolomics and lipidomics studies, the detection and quantitation of Pls in the FF has not been investigated so far (Nandi et al., 2007; Revelli et al., 2009; Collado-Fernandez et al., 2012; Cataldi et al., 2013) . Follicular Pls probably come from plasma high-density lipoproteins, the only class of lipoproteins described in the FF, since other lipoprotein particles are too large and are excluded by the follicular basal lamina (Suchanek et al., 1988) .
The functions of the Pls are not fully understood but may be related to their antioxidant activity, related to the vinyl ether moiety of their Figure 3 Box plot of the total dimethylarginine-to-arginine (Total DMA/Arginine) (A), the sums of polyunsaturated choline plasmalogens (PUFA ae, μmol/L) (B) and unsaturated-to-saturated choline plasmalogens (UFA /SFA ae) ratios (arbitrary units) (C) in the DOR and NOR patients. All the patients (n=57) were included. P-values were obtained using the Mann-Whitney test. alkenyl chain, which has the ability to scavenge oxygen radicals (Broniec et al., 2011) . Their protective role has been evidenced in mutant cells deficient in the biosynthesis of Pls (Zoeller et al., 1999) as well as by the enrichment of lipoproteins and liposomal membranes with Pls that increase their oxidative resistance (Engelmann et al., 1994) . Interestingly, a marked decrease in serum plasmalogen levels with ageing has been reported to be potentially linked with a redox imbalance (Maeba et al., 2007) . One hypothesis is that the diminution of polyunsaturated ChoPls in the FF of patients with ovarian ageing may be related to oxidative stress leading to excessive consumption of these molecules. This would corroborate previous studies showing, associated with ageing or DOR, increased oxidative stress in ovarian follicular environment (Carbone et al., 2003; Elizur et al., 2014; Nuñez-Calonge et al., 2016) Pls can also act as reservoir for important polyunsaturated lipid mediators such as arachidonic acid or docosahexaenoic acid linked at the sn-2 position of the glycerol backbone and released from Pls under the action of phospholipase A 2 (PLA 2 ) (Maeba et al., 2015) . The diminution of Pls in the FF of DOR patients could be a consequence of their increased consumption because of the greater activity of PLA 2 during ageing, as described in brain tissue (André et al., 2006) . Interestingly, increased PLA 2 activity has also been found in the FF containing oocytes that were not fertilizable by ICSI (Ciepiela et al., 2015) , suggesting a link between impaired oocyte quality and PLA 2 activity.
Multivariate analysis also showed the relevance of the total dimethylated arginine to unmodified arginine ratio (Total DMA/Arg) in discriminating between the FF of NOR and DOR patients. Interestingly, this ratio was conversely correlated with the FSH level notably in DOR patients. The lower Total DMA/Arg ratio found in the FF of DOR patients could be a consequence of the reduced activity of protein arginine methyl transferases (PRMTs) during ovarian ageing. Interestingly, a recent review indicates that the loss of PRMTs in transgenic mice is associated with cellular senescence and premature ageing (Blanc et al., 2017) .
PRMTs catalyze the symmetric or asymmetric methylation of arginine residues, (Bachand, 2007) and arginine methylation is a common post-translational modification playing a key role in gene expression, chromatin-based processes and epigenetic control. Hence, PRMTs are of particular importance for germinal cell development, oocyte quality and embryogenesis (Torres-Padilla et al., 2007; Stein et al., 2012; Kim et al., 2014; Baumann et al., 2015) . Moreover, low levels of PRMT1 have been associated with high rates of spontaneous DNA damage and aneuploidies whereas the total loss of PRMT1 in PRMT1-null mice has led to preimplantation embryonic lethality (Yu et al., 2009; Gurunathan et al., 2015) . DOR is associated with impaired oocyte quality resulting in embryonic aneuploidies (Haadsma et al., 2010; van der Stroom et al., 2011; Katz-Jaffe et al., 2013) , fertilization failure (Lekamge et al., 2007) , and pregnancy loss (Levi et al., 2001; Lekamge et al., 2007) . Our results support the hypothesis that altered oocyte quality in this context and its consequences could be related to a decreased expression of the PRMTs in the follicular environment associated with DOR. Overall, our study shows the impact of ovarian ageing on the composition of the FF, with a distinct signature of polyunsaturated ChoPls and methyl transferase activity. Whereas these compounds have been associated in the literature with aging and more or less directly with oocyte quality, it is premature to elaborate physiopathological hypotheses on this basis. But interestingly, at least in serum the decrease of PLs during ageing has been linked with redox imbalance associated with decreased activity of the peroxisomeactivated receptor gamma co-activator-1α (Maeba et al., 2007) , a master regulator of metabolism that is notably activated by PRMTs (Teyssier et al., 2005) .
In conclusion, these results call for further evaluation of the role of PRMTs and plasmalogens in ovarian ageing, perhaps by the use of broader, non-targeted metabolic analyses of FF, notably in view of a better understanding of the role played by other lipids, such as the ethanolamine plasmalogens, and their relationship to choline plasmalogens. Further studies will be needed to explore the pathways in which these compounds are involved, as well as their possible links with each other, to fully elucidate their involvement in the pathophysiology of DOR.
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